Risk factors
Vera Therapeutics (VERA) risk factors
Item 1A of every Vera Therapeutics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors89 risks13 new25 dropped23 reworded
Vera reported net losses of $299.6 million for 2025 with an accumulated deficit of $760.9 million. Capital needs and macroeconomic threats dominate the new risk disclosures. Product references were generalized across clinical candidates.
Filed Feb 26, 2026 - FY2024 10-K risk factors101 risks
Vera Therapeutics faces heavy financial losses and debt constraints while developing lead candidate atacicept and others.
Filed Feb 28, 2025